bf/NASDAQ:NAUT_icon.jpeg

NASDAQ:NAUT

Nautilus Biotechnology, Inc.

  • Stock

USD

Last Close

2.88

26/07 20:00

Market Cap

284.35M

Beta: 0.81

Volume Today

55.14K

Avg: 103.59K

PE Ratio

−5.53

PFCF: −8.75

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.nautilus.bio
  • ipo date

    Aug 07, 2020

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered i...Show More

peer of

Earnings per Share (Estimate*)

102030402018-12-312020-06-082021-08-102022-11-012024-02-22

Revenue (Estimate*)

0.000.000.010.010.012018-12-312020-06-082021-08-102022-11-012024-02-22

*Estimate based on analyst consensus